Toyama Chemical To Apply For Final Stage Trial For Flu Drug Favipiravir
This article was originally published in PharmAsia News
Executive Summary
Japanese drug maker Toyama Chemical plans to submit an application to commence a final Phase III trial for novel flu drug T-705 (favipiravir) within the month